Skip to main content

Advertisement

SpringerLink
Log in

Differentially expressed lncRNAs in peripheral blood mononuclear cells from middle-aged female patients with rheumatoid arthritis–associated interstitial lung disease

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objectives

Interstitial lung disease (ILD) is frequently associated with rheumatoid arthritis (RA) and has a large impact on the prognosis of RA, particularly among females, with an increased prevalence and severity compared with that of males. Here, we aimed to investigate the lncRNA profiles in peripheral blood mononuclear cells (PBMCs) from middle-aged female patients with RA-ILD to determine whether they could help diagnose RA-ILD.

Method

We collected PBMCs from middle-aged female healthy controls, and RA and RA-ILD patients, excluding those with known risk factors of RA-ILD, such as being elderly or male, smoking, and having a history of other diseases. Then, a microarray analysis was applied to profile the lncRNA and mRNA levels in 3 pairs of samples. qPCR was performed to evaluate the candidate lncRNAs from 20 participants of each group.

Results

The expression levels of NR_002819, NR_038935, and ENST00000603415 were significantly increased in the RA-ILD group, while the expression level of ENST00000560199 was significantly decreased. As risk factors for RA-ILD, the area under the curve (AUC) values of NR_002819, NR_038935, and ENST00000603415 were 0.858, 0.704 (medium diagnostic accuracy), and 0.976 (high diagnostic accuracy), respectively. As a protective factor for RA-ILD, the AUC of ENST00000560199 was 0.853(medium diagnostic accuracy).

Conclusions

To the best of our knowledge, this is the first study of lncRNA profiles in RA-ILD. The expression levels of NR_002819 (MALAT1), NR_038935, ENST00000603415, and ENST00000560199 were significantly different in the RA-ILD group and could be potential biomarkers for the assessment and diagnosis of middle-aged female RA-ILD patients.

Key Points

• The expression profile of lncRNAs in PBMCs from RA-ILD patients was evaluated.

• NR_002819, NR_038935, and ENST00000603415 increased in RA-ILD patients.

•ENST00000560199 decreased in RA-ILD patients.

• The 4 lncRNAs might be potential biomarkers for diagnosis of RA-ILD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29(1):62–67

    PubMed  Google Scholar 

  2. Wu EK, Ambrosini RD, Kottmann RM, Ritchlin CT, Schwarz EM, Rahimi H (2019) Reinterpreting evidence of rheumatoid arthritis-associated interstitial lung disease to understand etiology. Curr Rheumatol Rev 15(4):277–289. https://doi.org/10.2174/1573397115666190116102451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fu Q, Wang L, Li L, Li Y, Liu R, Zheng Y (2019) Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population. Clin Rheumatol 38(4):1109–1116. https://doi.org/10.1007/s10067-018-4382-x

    Article  PubMed  Google Scholar 

  4. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE Jr, Kim DS, Collard HR, Lee JS (2017) The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med 127:51–56. https://doi.org/10.1016/j.rmed.2017.04.012

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bell RD, Wu EK, Rudmann CA, Forney M, Kaiser CRW, Wood RW, Chakkalakal JV, Paris ND, Klose A, Xiao GQ, Rangel-Moreno J, Garcia-Hernandez ML, Ritchlin CT, Schwarz EM, Rahimi H (2019) Selective sexual dimorphisms in musculoskeletal and cardiopulmonary pathologic manifestations and mortality incidence in the tumor necrosis factor-transgenic mouse model of rheumatoid arthritis. Arthritis Rheum 71(9):1512–1523. https://doi.org/10.1002/art.40903

    Article  CAS  Google Scholar 

  6. Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR, Lee JS (2017) Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respir Med 127:1–6. https://doi.org/10.1016/j.rmed.2017.04.002

    Article  PubMed  PubMed Central  Google Scholar 

  7. Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, Swigris JJ (2019) Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol 46(4):360–369. https://doi.org/10.3899/jrheum.171315

    Article  PubMed  Google Scholar 

  8. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, Murphy J, Cohen M, Raghu G, Brown KK (2011) Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183(3):372–378. https://doi.org/10.1164/rccm.201004-0622OC

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gregersen PK, Gravallese EM (2018) Breathing new life into interstitial lung disease in rheumatoid arthritis. N Engl J Med 379(23):2265–2266. https://doi.org/10.1056/NEJMe1811767

    Article  PubMed  Google Scholar 

  10. Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, Kokosi M, Egashira R, Brun AL, Cross G, Barnett J, Devaraj A, Margaritopoulos G, Karwoski R, Renzoni E, Maher TM, Wells AU (2019) Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J 53(1):1800869. https://doi.org/10.1183/13993003.00869-2018

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bartels CM, Bell CL, Shinki K, Rosenthal A, Bridges AJ (2010) Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford) 49(9):1670–1675. https://doi.org/10.1093/rheumatology/keq135

    Article  Google Scholar 

  12. Suda T (2015) Up-to-date information on rheumatoid arthritis-associated interstitial lung disease. Clin Med Insights Circ Respir Pulm Med 9(Suppl 1):155–162. https://doi.org/10.4137/ccrpm.S23289

    Article  PubMed  Google Scholar 

  13. Luo Q, Xu C, Li X, Zeng L, Ye J, Guo Y, Huang Z, Li J (2017) Comprehensive analysis of long non-coding RNA and mRNA expression profiles in rheumatoid arthritis. Exp Ther Med 14(6):5965–5973. https://doi.org/10.3892/etm.2017.5284

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kowalczyk MS, Higgs DR, Gingeras TR (2012) Molecular biology: RNA discrimination. Nature 482(7385):310–311. https://doi.org/10.1038/482310a

    Article  CAS  PubMed  Google Scholar 

  15. Liang J, Chen W, Lin J (2019) lncRNA: an all-rounder in rheumatoid arthritis. J Transl Int Med 7(1):3–9. https://doi.org/10.2478/jtim-2019-0002

    Article  PubMed  PubMed Central  Google Scholar 

  16. Liu X, Gao S, Xu H (2018) lncRNAPCAT29 inhibits pulmonary fibrosis via the TGFbeta1 regulated RASAL1/ERK1/2 signal pathway. Mol Med Rep 17(6):7781–7788. https://doi.org/10.3892/mmr.2018.8807

    Article  CAS  PubMed  Google Scholar 

  17. Lu Q, Guo Z, Xie W, Jin W, Zhu D, Chen S, Ren T (2018) The lncRNA H19 mediates pulmonary fibrosis by regulating the miR-196a/COL1A1 Axis. Inflammation 41(3):896–903. https://doi.org/10.1007/s10753-018-0744-4

    Article  CAS  PubMed  Google Scholar 

  18. Yuan M, Wang S, Yu L, Qu B, Xu L, Liu L, Sun H, Li C, Shi Y, Liu H (2017) Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis. PLoS One 12(11):e0186795. https://doi.org/10.1371/journal.pone.0186795

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 36(4):817–823. https://doi.org/10.1007/s10067-017-3561-5

    Article  PubMed  Google Scholar 

  20. Choi WI, Dauti S, Kim HJ, Park SH, Park JS, Lee CW (2018) Risk factors for interstitial lung disease: a 9-year nationwide population-based study. BMC Pulm Med 18(1):96. https://doi.org/10.1186/s12890-018-0660-2

    Article  PubMed  PubMed Central  Google Scholar 

  21. Assayag D, Lee JS, King TE Jr (2014) Rheumatoid arthritis associated interstitial lung disease: a review. Medicina (B Aires) 74(2):158–165

    Google Scholar 

  22. Dong Z, Li S, Wu X, Niu Y, Liang X, Yang L, Guo Y, Shen S, Liang J, Guo W (2019) Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma. Cell Death Dis 10(12):930. https://doi.org/10.1038/s41419-019-2171-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, Gill RR, Hatabu H, Nishino M, Murphy DJ, Iannaccone CK, Mahmoud TG, Frits ML, Lu B, Rosas IO, Dellaripa PF, Weinblatt ME, Karlson EW, Shadick NA, Doyle TJ (2019) Rheumatoid arthritis disease activity predicting incident clinically-apparent RA-associated interstitial lung disease: a prospective cohort study. Arthritis Rheum 71(9):1472–1482. https://doi.org/10.1002/art.40904

    Article  CAS  Google Scholar 

  24. Kiely P, Busby AD, Nikiphorou E, Sullivan K, Walsh DA, Creamer P, Dixey J, Young A (2019) Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open 9(5):e028466. https://doi.org/10.1136/bmjopen-2018-028466

    Article  PubMed  PubMed Central  Google Scholar 

  25. Furukawa H, Oka S, Shimada K, Sugii S, Ohashi J, Matsui T, Ikenaka T, Nakayama H, Hashimoto A, Takaoka H, Arinuma Y, Okazaki Y, Futami H, Komiya A, Fukui N, Nakamura T, Migita K, Suda A, Nagaoka S, Tsuchiya N, Tohma S (2012) Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope. PLoS One 7(5):e33133. https://doi.org/10.1371/journal.pone.0033133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, Gonzalez-Perez MI, Mejia M, Buendia-Roldan I, Falfan-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Liote H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clement A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieude P (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med 379(23):2209–2219. https://doi.org/10.1056/NEJMoa1801562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gutschner T, Hammerle M, Diederichs S (2013) MALAT1 -- a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 91(7):791–801. https://doi.org/10.1007/s00109-013-1028-y

    Article  CAS  Google Scholar 

  28. Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X (2015) MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol 36(3):1477–1486. https://doi.org/10.1007/s13277-014-2631-4

    Article  CAS  PubMed  Google Scholar 

  29. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, Prasanth KV (2013) Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 9(3):e1003368. https://doi.org/10.1371/journal.pgen.1003368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gordon AD, Biswas S, Feng B, Chakrabarti S (2018) MALAT1: a regulator of inflammatory cytokines in diabetic complications. Endocrinol Diabetes Metab 1(2):e00010. https://doi.org/10.1002/edm2.10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhou HJ, Wang LQ, Wang DB, Yu JB, Zhu Y, Xu QS, Zheng XJ, Zhan RY (2018) Long noncoding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via the modulation of a miR-199b/IKKbeta/NF-kappaB signaling pathway. Am J Phys Cell Phys 315(1):C52–c61. https://doi.org/10.1152/ajpcell.00278.2017

    Article  CAS  Google Scholar 

  32. Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, Boon RA, Dimmeler S (2014) Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 114(9):1389–1397. https://doi.org/10.1161/circresaha.114.303265

    Article  CAS  PubMed  Google Scholar 

  33. Song J, Kim D, Han J, Kim Y, Lee M, Jin EJ (2015) PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med 15(1):121–126. https://doi.org/10.1007/s10238-013-0271-4

    Article  CAS  PubMed  Google Scholar 

  34. Pan F, Zhu L, Lv H, Pei C (2016) Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1. Int J Mol Med 38(5):1507–1514. https://doi.org/10.3892/ijmm.2016.2755

    Article  CAS  PubMed  Google Scholar 

  35. Li GQ, Fang YX, Liu Y, Meng FR, Wu X, Zhang CW, Zhang Y, Liu D, Gao B (2019) MALAT1-driven inhibition of Wnt signal impedes proliferation and inflammation in fibroblast-like synoviocytes through CTNNB1 promoter methylation in rheumatoid arthritis. Hum Gene Ther 30(8):1008–1022. https://doi.org/10.1089/hum.2018.212

    Article  CAS  PubMed  Google Scholar 

  36. Newman DR, Sills WS, Hanrahan K, Ziegler A, Tidd KM, Cook E, Sannes PL (2016) Expression of WNT5A in idiopathic pulmonary fibrosis and its control by TGF-beta and WNT7B in human lung fibroblasts. J Histochem Cytochem 64(2):99–111. https://doi.org/10.1369/0022155415617988

    Article  CAS  PubMed  Google Scholar 

  37. Shi J, Chi S, Xue J, Yang J, Li F, Liu X (2016) Emerging role and therapeutic implication of Wnt signaling pathways in autoimmune diseases. J Immunol Res 2016:9392132. https://doi.org/10.1155/2016/9392132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner DL, Messersmith WA, Lieu CH (2015) Targeting the WNT signaling pathway in cancer therapeutics. Oncologist 20(10):1189–1198. https://doi.org/10.1634/theoncologist.2015-0057

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sen M, Reifert J, Lauterbach K, Wolf V, Rubin JS, Corr M, Carson DA (2002) Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 46(11):2867–2877. https://doi.org/10.1002/art.10593

    Article  CAS  PubMed  Google Scholar 

  40. Chen L, Tang RZ, Ruan J, Zhu XB, Yang Y (2019) Up-regulation of THY1 attenuates interstitial pulmonary fibrosis and promotes lung fibroblast apoptosis during acute interstitial pneumonia by blockade of the WNT signaling pathway. Cell Cycle 18(6–7):670–681. https://doi.org/10.1080/15384101.2019.1578144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Yu M, Guo Y, Zhang P, Xue J, Yang J, Cai Q, You X, Ma J, Yang D, Jia Y, Wang Y, Li F, Chi S, Cao M, Chen J, Liu X (2019) Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD). Immunobiology 224(4):551–559. https://doi.org/10.1016/j.imbio.2019.04.006

    Article  CAS  PubMed  Google Scholar 

  42. Ahangari F, Kaminski N (2018) WNT5a in extracellular vesicles - a new frontier for pulmonary fibrosis. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.201807-1321ED

  43. Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C, Spector DL (2012) The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep 2(1):111–123. https://doi.org/10.1016/j.celrep.2012.06.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Eissmann M, Gutschner T, Hammerle M, Gunther S, Caudron-Herger M, Gross M, Schirmacher P, Rippe K, Braun T, Zornig M, Diederichs S (2012) Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 9(8):1076–1087. https://doi.org/10.4161/rna.21089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Nakagawa S, Ip JY, Shioi G, Tripathi V, Zong X, Hirose T, Prasanth KV (2012) Malat1 is not an essential component of nuclear speckles in mice. Rna 18(8):1487–1499. https://doi.org/10.1261/rna.033217.112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank MD. Yan Huang from the Harbin Institute of Technology for assistance with the data analysis.

Funding

This work was supported by the National Natural Science Foundation of China (No. 81371929).

Author information

Authors and Affiliations

  1. Department of Rheumatology, Shandong University Qilu Hospital, 107 Wenhua Xi Road, Jinan, 250012, Shandong Province, China

    Wei Zhou & Huaxiang Liu

  2. Department of Rheumatology, Liaocheng People’s Hospital, Liaocheng, 252000, China

    Wei Zhou & Min Yuan

  3. Department of the Key Laboratory of Ophthalmology, Liaocheng People’s Hospital, Liaocheng, 252000, China

    Juan Zheng & Xiaodong Jia

  4. Department of Pneumology, Liaocheng People’s Hospital, Liaocheng, 252000, China

    Lindong Yuan

Authors
  1. Wei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lindong Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaodong Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huaxiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Huaxiang Liu.

Ethics declarations

Ethical approval for this study was provided by the Research Ethics Committee of the Liaocheng People’s Hospital (registration number 2016083). All participants provided a statement of consent.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, W., Zheng, J., Yuan, M. et al. Differentially expressed lncRNAs in peripheral blood mononuclear cells from middle-aged female patients with rheumatoid arthritis–associated interstitial lung disease. Clin Rheumatol 39, 2281–2289 (2020). https://doi.org/10.1007/s10067-020-04977-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-04977-w

Keywords

Search

Navigation